Edward Boyko chairs 10th edition of IDF Diabetes Atlas
Dr. Edward J Boyko, professor (General internal Medicine) served as co-chair for the recently released 10th edition of the International Diabetes Federation (IDF) Diabetes Atlas with co-chair Prof. Dianna Magliano, Baker Heart and Diabetes Institute, Melbourne, Australia.
Boyko is the founding and former Director of the VA-funded Seattle Epidemiologic Research and Information Center (ERIC) and serves as principal investigator of the Japanese American Community Diabetes Study, co-principal investigator of the DoD/VA Millennium Cohort Study, and local site investigator for the Million Veteran Program and the VA All of Us Program.
Diabetes is one of the fastest growing global health emergencies of the 21st century
The IDF Diabetes Atlas has estimated global prevalence of diabetes for over 20 years, advocating for proven and effective actions toward progress in diagnosis, care and prevention for academics, policy makers and nongovernmental organizations.
The IDF Atlas is recognized as the leading authority on diabetes burden in the world with estimates for every country and several territories.
Special topics are highlighted in each Atlas and in this edition include impact of COVID-19 on diabetes, type 2 diabetes in youth, and type 1 diabetes in adults. Additional informational resources are available on the Atlas website.
The current IDF Diabetes Atlas selected 219 data sources from 144 countries comprising 93% of the population to estimate diabetes prevalence and future projections have been calculated using the United Nations population predictions and degree of urbanization.
Key findings from the 10th Edition:
537 million adults (20-79 years) are living with diabetes - 1 in 10. This number is predicted to rise to 643 million by 2030 and 783 million by 2045.
Over 3 in 4 adults with diabetes live in low- and middle-income countries.
Diabetes is responsible for 6.7 million deaths in 2021 - 1 every 5 seconds.
Diabetes caused at least USD 966 billion dollars in health expenditure – a 316% increase over the last 15 years.
541 million adults have Impaired Glucose Tolerance (IGT), which places them at high risk of type 2 diabetes.